IL-2 enhances effector function but suppresses follicular localization of CD8 + T cells in chronic infection

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Cytotoxic CD8 + T cells, essential in combating viral infections and cancer, become dysfunctional from prolonged antigen exposure. Precursors of exhausted T (T PEX ) cells are pivotal in sustaining immune responses in chronic diseases and mediating immunotherapy efficacy. They also control viral infection within B-cell follicles, facilitated by CXCR5 expression. How cytokines regulate T PEX cell fate and follicular entry is not well understood. We reveal that IL-2 treatment enhances CD8 + T cell effector functions in chronic LCMV infection but hinders CXCR5 + T PEX cell formation and infection control within B-cell follicles. Mechanistically, IL-2 suppresses T PEX cell differentiation in a STAT5 and BLIMP1-dependent manner. Using an IL-2 fusion protein targeting CD122, we shifted the differentiation towards CX3CR1 + T cells with increased effector function. Clinical observations with low-dose IL-2 in autoimmune disease confirmed IL-2’s inhibitory effect on CXCR5 + T PEX cells, underscoring IL-2’s crucial regulatory role and therapeutic potential in modulating T PEX and effector T cell generation.

Article activity feed